购物车
- 全部删除
- 您的购物车当前为空
Tyrosinase-IN-13 (compound 3c)为Flurbiprofen的衍生物,具有非竞争性酪氨酸酶抑制活性(IC50=68 μM;Ki=36.3 μM),并对肝细胞癌(HepG2)、结直肠癌(HT-29)及黑色素瘤(B16F10)细胞表现出细胞毒性。
Tyrosinase-IN-13 (compound 3c)为Flurbiprofen的衍生物,具有非竞争性酪氨酸酶抑制活性(IC50=68 μM;Ki=36.3 μM),并对肝细胞癌(HepG2)、结直肠癌(HT-29)及黑色素瘤(B16F10)细胞表现出细胞毒性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Tyrosinase-IN-13 (compound 3c), stemming from Flurbiprofen, acts as a potent non-competitive inhibitor of tyrosinase, exhibiting IC50 and Ki values of 68 μM and 36.3 μM respectively. This compound demonstrates cytotoxicity against several cancer cell lines, including hepatocellular carcinoma (HepG2), colorectal cancer (HT-29), and melanoma (B16F10) [1]. |
分子量 | 452.93 |
分子式 | C23H18ClFN4OS |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容